Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Methylation

NCT01695018 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT01695018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Methylation
Lead sponsor
Peking University
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
Not reported
Enrollment
180 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild epithelial dysplasia, moderate epithelial dysplasia